CD19 and neoplasm: For example, introduction of CD19 CAR into stem cell memory T cells (TSCM), the most primitive subset of memory T cells with self-renewing capacity [68], resulted in enhanced in vitro proliferation activity as well as prolonged in vivo persistence and better tumor control compared to conventional CAR T cells [69].